Back to
RENAISSANCE TECHNOLOGIES LLC
ACRS
Showing 8 of 28 quarters
Position history for
RENAISSANCE TECHNOLOGIES LLC's holdings in ACLARIS THERAPEUTICS INC
Yes. Renaissance Technologies holds 817,531 shares of ACRS (Aclaris Therapeutics), worth $4.3M, as of its Q2 2026 13F filing. It increased the position by 314,900 shares (+62.7%) from Q1 2026. Renaissance Technologies has held ACRS in every 13F on record since Q3 2019, 28 quarterly filings.
Current Value
$4.3M
Current Shares
817,531
Total Value Change
+$2.7M
Total Shares Change
-553,169
Quarter-by-Quarter History